Results
Sun Pharma FY26 Net Profit Rises 5% to ₹114.8 Billion
Sun Pharma reported 11.9% YoY growth in FY26 consolidated revenue to ₹582.2 billion and 5% rise in net profit to ₹114.8 billion.
The Board recommended a final dividend of ₹5 per share, bringing total
